#BEGIN_DRUGCARD DB02688

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
1948-56-7

# ChEBI_ID:
17123

# Chemical_Formula:
C3H5NO2

# Chemical_IUPAC_Name:
2-aminoprop-2-enoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2,3-Didehydroalanine

# HET_ID:
DHA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C3H5NO2/c1-2(4)3(5)6/h1,4H2,(H,5,6)

# InChI_Key:
InChIKey=UQBOJOOOTLPNST-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C02218

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2688

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
87.0773

# Molecular_Weight_Mono:
87.032028409

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1MQX

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.13

# Predicted_LogS:
0.43

# Predicted_Water_Solubility:
2.33e+02 g/l

# Primary_Accession_No:
DB02688

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
123991

# PubChem_Substance_ID:
46509183

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01186

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC(=C)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:23 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Z47559

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
mrsA

# Drug_Target_1_Gene_Sequence:
>207 bp
ATGAGTCAAGAAGCTATCATTCGTTCATGGAAAGATCCTTTTTCCCGTGAAAATTCTACA
CAAAATCCAGCTGGTAACCCATTCAGTGAGCTGAAAGAAGCACAAATGGATAAGTTAGTA
GGTGCGGGAGACATGGAAGCAGCATGTACTTTTACATTGCCTGGTGGCGGCGGTGTTTGT
ACTCTAACTTCTGAATGTATTTGTTAA

# Drug_Target_1_General_Function:
Not Available

# Drug_Target_1_General_References:
10818347	Schneider TR, Karcher J, Pohl E, Lubini P, Sheldrick GM: Ab initio structure determination of the lantibiotic mersacidin. Acta Crystallogr D Biol Crystallogr. 2000 Jun;56(Pt 6):705-13.
10831439	Altena K, Guder A, Cramer C, Bierbaum G: Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster. Appl Environ Microbiol. 2000 Jun;66(6):2565-71.
7737474	Bierbaum G, Brotz H, Koller KP, Sahl HG: Cloning, sequencing and production of the lantibiotic mersacidin. FEMS Microbiol Lett. 1995 Mar 15;127(1-2):121-6.
9119018	Prasch T, Naumann T, Markert RL, Sattler M, Schubert W, Schaal S, Bauch M, Kogler H, Griesinger C: Constitution and solution conformation of the antibiotic mersacidin determined by NMR and molecular dynamics. Eur J Biochem. 1997 Mar 1;244(2):501-12.
9210483	Brotz H, Bierbaum G, Reynolds PE, Sahl HG: The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Eur J Biochem. 1997 May 15;246(1):193-9.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4551

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
7228

# Drug_Target_1_Name:
Lantibiotic mersacidin

# Drug_Target_1_Number_of_Residues:
68

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
>Lantibiotic mersacidin
MSQEAIIRSWKDPFSRENSTQNPAGNPFSELKEAQMDKLVGAGDMEAACTFTLPGGGGVC
TLTSECIC

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Kills a number of Gram-positive bacteria. Acts at the level of cell wall biosynthesis by interfering with bacterial peptidoglycan biosynthesis. Specifically inhibits the conversion of the lipid II intermediate into polymeric nascent glycan strands by transglycosylation. May interact with the peptidoglycan precursor rather than with the enzyme

# Drug_Target_1_SwissProt_ID:
P43683

# Drug_Target_1_SwissProt_Name:
MRSA_BACSY

# Drug_Target_1_Synonyms:
Lantibiotic mersacidin precursor

# Drug_Target_1_Theoretical_pI:
4.17

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02688
